Back to Newsroom

Conatus Pharmaceuticals Announces Poster Presentations at AASLD Annual Meeting

SAN DIEGO , Nov. 14, 2016 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) announced today the presentation of four posters — two addressing clinical results and two addressing preclinical results with the company’s pan-caspase inhibitor, emricasan — at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston November 11-15, 2016.

Click here to read the full release